businesspress24.com - ZELTIQ to Present at J.P. Morgan 33rd Annual Healthcare Conference
 

ZELTIQ to Present at J.P. Morgan 33rd Annual Healthcare Conference

ID: 1329937

Investor Presentation Now Available on Corporate Website

(firmenpresse) - PLEASANTON, CA -- (Marketwired) -- 01/13/15 -- ZELTIQ®, (NASDAQ: ZLTQ) a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, CoolSculpting®, will present at the J.P. Morgan 33rd Annual Healthcare Conference tomorrow, Wednesday, January 14, 2015. President and Chief Executive Officer, Mark Foley, will present at 7:30 a.m. PT / 10:30 a.m. ET at the Westin St. Francis Hotel in San Francisco. A copy of ZELTIQ''s investor presentation is available on the investor relations section of ZELTIQ''s web site, at .

In anticipation of the event, the Company has posted its investor presentation under the Investor Relations section of ZELTIQ''s website at . An audio webcast of the Company''s presentation will be available by visiting the investor relations web site. A replay of the presentation will be available for 90 days.

ZELTIQ is a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform. ZELTIQ''s first commercial product, the CoolSculpting® System, is designed to selectively reduce stubborn fat bulges. CoolSculpting is based on the scientific principle that fat cells are more sensitive to cold than the overlying skin and surrounding tissues. It utilizes patented technology of precisely controlled cooling to reduce the temperature of fat cells in the treated area, which is intended to cause fat cell elimination through a natural biological process known as apoptosis. ZELTIQ developed CoolSculpting to safely, noticeably, and measurably reduce the fat layer.






Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Christopher Homes Unveils New Model Homes At Azalea In Rosedale
iSatori Launches Its Newest Patented Weight-Loss Pill -- DygloTrim(TM) With Dyglomera(R), Under the BioGenetics Brand, to Retail Stores Nationwide
Bereitgestellt von Benutzer: Marketwired
Datum: 13.01.2015 - 19:10 Uhr
Sprache: Deutsch
News-ID 1329937
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

PLEASANTON, CA


Phone:

Kategorie:

Personal Care & Fitness


Anmerkungen:


Diese Pressemitteilung wurde bisher 212 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"ZELTIQ to Present at J.P. Morgan 33rd Annual Healthcare Conference
"
steht unter der journalistisch-redaktionellen Verantwortung von

ZELTIQ Aesthetics, Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von ZELTIQ Aesthetics, Inc.



 

Who is online

All members: 10 591
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 119


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.